-
Viridian Appoints Scott Myers as President and Chief Executive Officer
06 Feb 2023 12:00 GMT
… Myers as President and Chief Executive Officer, and a member … served as the CEO and Director of AMAG Pharmaceuticals, where he led … Previous roles include serving as CEO, President and Director of … a medical technology company. While CEO of these companies, Mr. …
-
Viridian Therapeutics hires three Magenta executives, replaces CEO and signs $185M private placement
30 Oct 2023 15:05 GMT
… Mahoney joined Viridian Therapeutics as CEO on Monday, with the former … the autoimmune biotech’s third chief executive in less than 12 months … had led AMAG Pharmaceuticals before signing on as Viridian CEO in February when …
-
Landsdowne Labs Names Bryan Laulicht CEO
13 Jun 2023 13:33 GMT
… appointment of Bryan Laulicht to Chief Executive Officer.
Laulicht, a company cofounder … requiring urgent surgery—acquired by AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG).
Laulicht holds … -founder who has served as CEO since 2017. Under Fensterstock’s …
-
Viridian Therapeutics Names Scott Myers CEO, Succeeding Jonathan Violin
06 Feb 2023 14:53 GMT
… Scott Myers as President and Chief Executive Officer, and a member of … recently served as the CEO and Director of AMAG Pharmaceuticals, where he led … AMAG, he served as CEO and Chairman of the Board … He had also worked as CEO of Cascadian Therapeutics until its …
-
Viridian Therapeutics Names Myers CEO as Violin Resigns >VRDN
06 Feb 2023 12:34 GMT
… Violin has resigned as president, chief executive and a member of the … , who most recently served as CEO of AMAG Pharmaceuticals, succeeds Mr. Violin in …
-
AMAG Pharmaceuticals Files Submission in Response To the Food And Drug Administration’s Notice of Opportunity for a Hearing and Proposal To Withdraw Approval of Makena® (hydroxyprogesterone caproate injection)
14 Dec 2020 13:47 GMT
… . 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. has submitted its response … U.S. patients,” said Covis CEO Michael Porter. “We stand ready …
-
Covis Group Completes Acquisition of AMAG Pharmaceuticals
16 Nov 2020 14:59 GMT
… completion of its acquisition of AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) … be led by Covis CEO Michael Porter.
The addition … ," said Michael Porter, CEO of Covis. "AMAG… -group-completes-acquisition-of-amag-pharmaceuticals-301173667.html
SOURCE Covis …
-
AMAG Pharmaceuticals Requests Hearing to Maintain Makena® (Hydroxyprogesterone Caproate Injection) as a Treatment Option for Clinically Indicated Pregnant Patients
14 Oct 2020 20:11 GMT
… Makena are concerning,” said AMAG CEO Scott Myers. “We remain committed … ’s hearing request, Covis Pharma CEO Michael Porter said, “We support … statements. AMAG Pharmaceuticals®, the logo and designs, are registered trademarks of AMAG Pharmaceuticals, Inc …
-
AMAG Pharmaceuticals Provides Update on FDA's Proposal Regarding Makena(R) (Hydroxyprogesterone Caproate Injection)
06 Oct 2020 01:12 GMT
… indicated women," said AMAG CEO Scott Myers. "We … contains forward-looking information about AMAG Pharmaceuticals, Inc. within the meaning … statements.
AMAG Pharmaceuticals, the logo and designs, are registered trademarks of AMAG Pharmaceuticals, …
-
AMAG Pharmaceuticals Provides Update on FDA’s Proposal Regarding Makena® (Hydroxyprogesterone Caproate Injection)
06 Oct 2020 01:05 GMT
… for indicated women,” said AMAG CEO Scott Myers. “We are … contains forward-looking information about AMAG Pharmaceuticals, Inc. within the meaning … statements. AMAG Pharmaceuticals®, the logo and designs, are registered trademarks of AMAG Pharmaceuticals, …
About
© 1995-2025